Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial
MJ Frank, MS Khodadoust, DK Czerwinski… - Journal of Experimental …, 2020 - rupress.org
Here, we report on the results of a phase I/II trial (NCT00490529) for patients with mantle cell
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial.
MJ Frank, MS Khodadoust, DK Czerwinski… - The Journal of …, 2020 - europepmc.org
Here, we report on the results of a phase I/II trial (NCT00490529) for patients with mantle cell
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
[PDF][PDF] Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial
MJ Frank, MS Khodadoust, DK Czerwinski… - J. Exp …, 2020 - scholar.archive.org
Here, we report on the results of a phase I/II trial (NCT00490529) for patients with mantle cell
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial
MJ Frank, MS Khodadoust… - The Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Here, we report on the results of a phase I/II trial (NCT00490529) for patients with mantle cell
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
[HTML][HTML] Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial
MJ Frank, MS Khodadoust, DK Czerwinski… - The Journal of …, 2020 - ncbi.nlm.nih.gov
Here, we report on the results of a phase I/II trial (NCT00490529) for patients with mantle cell
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
[引用][C] Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial
MJ Frank, MS Khodadoust… - Journal of …, 2020 - scholars.ntou.edu.tw
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with
mantle cell lymphoma: A phase I/II trial | National Taiwan Ocean University Research Hub …
mantle cell lymphoma: A phase I/II trial | National Taiwan Ocean University Research Hub …
[HTML][HTML] Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial
MJ Frank, MS Khodadoust, DK Czerwinski… - Journal of Experimental …, 2020 - rupress.org
Here, we report on the results of a phase I/II trial (NCT00490529) for patients with mantle cell
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial.
MJ Frank, MS Khodadoust, DK Czerwinski… - The Journal of …, 2020 - europepmc.org
Here, we report on the results of a phase I/II trial (NCT00490529) for patients with mantle cell
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …
lymphoma who, having achieved remission after immunochemotherapy, were vaccinated …